Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
BACKGROUND
It is of great significance to find better markers to correctly distinguish between high-risk and low-risk breast cancer patients since the majority of breast cancer cases are at present being overtreated.


METHODS
46 tumours from node-negative breast cancer patients were studied with gene expression microarrays. A t-test was carried out in order to find a set of genes where the expression might predict clinical outcome. Two classifiers were used for evaluation of the gene lists, a correlation-based classifier and a Voting Features Interval (VFI) classifier. We then evaluated the predictive accuracy of this expression signature on tumour sets from two similar studies on lymph-node negative patients. They had both developed gene expression signatures superior to current methods in classifying node-negative breast tumours. These two signatures were also tested on our material.


RESULTS
A list of 51 genes whose expression profiles could predict clinical outcome with high accuracy in our material (96% or 89% accuracy in cross-validation, depending on type of classifier) was developed. When tested on two independent data sets, the expression signature based on the 51 identified genes had good predictive qualities in one of the data sets (74% accuracy), whereas their predictive value on the other data set were poor, presumably due to the fact that only 23 of the 51 genes were found in that material. We also found that previously developed expression signatures could predict clinical outcome well to moderately well in our material (72% and 61%, respectively).


CONCLUSIONS
The list of 51 genes derived in this study might have potential for clinical utility as a prognostic gene set, and may include candidate genes of potential relevance for clinical outcome in breast cancer. According to the predictions by this expression signature, 30 of the 46 patients may have benefited from different adjuvant treatment than they received.
Karlsson
Elin
E
Department of Oncology, Institute of Clinical Sciences, Blå stråket 2, University of Gothenburg, SE-413 45, Göteborg, Sweden. elin.karlsson@oncology.gu.se
Delle
Ulla
U
Danielsson
Anna
A
Olsson
Björn
B
Abel
Frida
F
Karlsson
Per
P
Helou
Khalil
K
D014408:Biomarkers, Tumor / Q000235:genetics*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D016000:Cluster Analysis; D005260:Female; D005500:Follow-Up Studies; D020869:Gene Expression Profiling; D006801:Humans; D053208:Kaplan-Meier Estimate; D008207:Lymphatic Metastasis; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis; D011237:Predictive Value of Tests; D011379:Prognosis
D014408:Biomarkers, Tumor
BMC Genomics. 2006 Oct 30;7:278
17074082
Hum Pathol. 2004 Oct;35(10):1196-209
15492986
Mol Cell Biol. 2003 Mar;23(6):2109-22
12612082
Bioinformatics. 2005 Jan 15;21(2):171-8
15308542
Hum Genet. 2002 Oct;111(4-5):411-20
12384785
Genome Biol. 2002 Jul 15;3(8):SOFTWARE0003
12186655
Nature. 2000 Aug 17;406(6797):747-52
10963602
Breast Cancer Res. 2006;8(5):R62
17069664
Cancer Genet Cytogenet. 2007 Jan 15;172(2):139-46
17213022
Bioinformatics. 2004 Oct 12;20(15):2479-81
15073010
Carcinogenesis. 2004 Dec;25(12):2311-7
15319300
Gene. 1998 Feb 16;208(1):25-30
9479038
Breast Cancer Res Treat. 2007 Jul;103(3):319-29
17123152
N Engl J Med. 2002 Dec 19;347(25):1999-2009
12490681
EMBO J. 2006 May 3;25(9):1848-59
16628223
Cancer. 2003 Nov 15;98(10):2133-43
14601082
Clin Cancer Res. 2005 Sep 1;11(17):6400-7
16144945
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5
16141321
Oncogene. 2007 Mar 1;26(10):1507-16
16936776
Bioinformatics. 2005 Apr 1;21(7):1280-1
15546938
Oncogene. 2006 Aug 3;25(33):4534-48
16547496
World J Gastroenterol. 2006 Sep 28;12(36):5884-9
17007058
Mol Cancer Ther. 2004 Feb;3(2):161-8
14985456
Cancer Res. 2004 May 1;64(9):3037-45
15126339
Nature. 2002 Jan 31;415(6871):530-6
11823860
BMC Cancer. 2007 Apr 11;7:61
17428335
Blood. 2006 Oct 15;108(8):2726-35
16763212
Breast Cancer Res Treat. 2009 Jan;113(2):231-7
18278552
Lancet. 2005 Feb 19-25;365(9460):671-9
15721472
DNA Repair (Amst). 2002 Jul 17;1(7):517-29
12509226
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
11553815
Nucleic Acids Res. 2007 Jan;35(Database issue):D760-5
17099226
J Cancer Res Clin Oncol. 2004 Sep;130(9):537-45
15235906
Hum Genet. 2006 Nov;120(4):581-8
16972078
Clin Cancer Res. 2006 Jul 1;12(13):3950-60
16818692
Breast Cancer. 2005;12(3):166-77
16110286
Blood. 2002 Jun 15;99(12):4540-6
12036886
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
16514137
Lancet. 2003 May 10;361(9369):1590-6
12747878
Mol Cell. 2001 Jul;8(1):105-13
11511364
J Clin Oncol. 2006 Oct 1;24(28):4594-602
17008701
BMC Mol Biol. 2006 Jan 31;7:3
16448564